Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
IPN60210
i
Other names:
IPN-60210, IPN60210, EZM-0414, EZM0414, EZM 0414, IPN 60210
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Ipsen
Drug class:
SETD2 inhibitor
‹
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
No biomarker
Diffuse Large B Cell Lymphoma
No biomarker
Diffuse Large B Cell Lymphoma
IPN60210
Sensitive: B - Late Trials
IPN60210
Sensitive
:
B
IPN60210
Sensitive: B - Late Trials
IPN60210
Sensitive
:
B
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.